Molecular prognostic markers in breast cancer

Breast Cancer Res Treat. 1998;52(1-3):185-200. doi: 10.1023/a:1006101729631.

Abstract

Based on the scientific literature, there are several molecular markers which might be used for the prognosis of breast cancer. Possible molecular prognostic markers are: BRCA-1, BRCA-2, p53, erbB oncogenes, loss of heterozygosity (LOH), chromosomal aberrations, microsatellite instability, transforming growth factor alpha (TGFalpha), and the multiple drug resistance (MDR) gene. In this chapter, we discuss the possible role of these prognostic markers in breast cancer.

Publication types

  • Review

MeSH terms

  • BRCA2 Protein
  • Breast Neoplasms / genetics*
  • Breast Neoplasms / mortality
  • Chromosome Aberrations
  • Drug Resistance, Multiple / genetics
  • Female
  • Genes, BRCA1
  • Genes, erbB-2
  • Genes, p53
  • Humans
  • Loss of Heterozygosity
  • Microsatellite Repeats
  • Neoplasm Proteins / genetics
  • Prognosis
  • Transcription Factors / genetics
  • Transforming Growth Factor alpha / analysis

Substances

  • BRCA2 Protein
  • Neoplasm Proteins
  • Transcription Factors
  • Transforming Growth Factor alpha